Core Insights - The lithium battery sector is experiencing a surge in interest, with companies like Tianji Co., Fengyuan Co., Jinyinhai Co., Hongxing Development, and Guanghua Technology leading the charge [1] Company Summaries - ***ST Zhengping (603843.SS)**: Achieved a "3 consecutive limit up" with a latest price of 3.07 yuan, up 5.14%. The company is focusing on resource expansion through lithium mining projects in Pakistan and Morocco, which is driving its stock price [1] - **Tianji Co. (002759.SZ)**: Secured a "2 consecutive limit up" with a latest price of 13.89 yuan, up 9.98%. As a leading player in lithium hexafluorophosphate, the company has an annual production capacity of 22,000 tons, benefiting from the growing demand for lithium batteries [2] - **Fengyuan Co. (002805.SZ)**: Recorded its first limit up with a latest price of 14.61 yuan, up 10.02%. The company has a dual-track strategy in lithium battery cathode materials, with a production capacity of 125,000 tons for lithium iron phosphate and 15,000 tons for ternary materials, establishing strong partnerships with major clients [3] - **Jinyinhai Co. (300619.SZ)**: Achieved a 20% limit up with a latest price of 33.16 yuan. The company is a leader in automated mixing equipment for lithium batteries and provides integrated solutions for both lithium-ion and sodium-ion battery production [4] - **Hongxing Development (600367.SS)**: Recorded its first limit up with a latest price of 18.01 yuan, up 10.02%. The company has significant production capacity in manganese-based lithium battery materials, with an annual output of 30,000 tons for both electrolytic manganese dioxide and high-purity manganese sulfate [5] - **Guanghua Technology (002741.SZ)**: Achieved its first limit up with a latest price of 22.35 yuan, up 9.99%. The company has a diverse range of lithium battery materials and is involved in the recycling of retired batteries, creating a closed-loop industry chain from material production to recycling [6]

Group 1 - The solid-state battery sector in the A-share market continues to show strong performance, with several companies experiencing significant stock price increases [1] - Patel's stock surged over 24%, while other companies like Jinyinhe and Huasheng Lithium Battery hit the daily limit of 20% increase [1] - Other notable performers include Lijia Technology with an increase of over 18%, and XianDao Intelligent with a rise of over 17% [1] Group 2 - Patel's total market capitalization is approximately 2.02 billion, with a year-to-date increase of 138.26% [2] - Jinyinhe has a market cap of 5.77 billion, with a year-to-date increase of 79.24% [2] - XianDao Intelligent's market cap stands at 82.5 billion, with a remarkable year-to-date increase of 163.72% [2]

Core Viewpoint - The company emphasizes the critical role of manganese in the development of solid-state batteries and acknowledges market judgments regarding this element [1] Production Capacity - The company has an annual production capacity of 30,000 tons for both electrolytic manganese dioxide and high-purity manganese sulfate [1] - The company possesses production technology for manganese tetroxide, which has completed pilot testing but has not yet produced any products [1]

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Key Points - The company will distribute a cash dividend of 0.03 CNY per share [1][2] - The total cash dividend to be distributed amounts to 10,233,927.06 CNY based on a total share capital of 341,130,902 shares [2] - The record date for shareholders is set for September 10, 2025, with the last trading day and ex-dividend date also on September 11, 2025 [1][2] - The profit distribution plan was approved by the board on August 21, 2025, and is not expected to exceed 30% of the net profit attributable to shareholders for the first half of 2025 [1][2] - The distribution will be managed by China Securities Depository and Clearing Corporation Limited, Shanghai Branch [2][3] - Shareholders who hold shares for more than one year will not be subject to individual income tax on the dividend [3][4] - For shareholders holding shares for one month or less, a 20% tax will be applied to the dividend income [4] - The net dividend after tax for overseas investors will be 0.027 CNY per share, subject to a 10% withholding tax [5][6]

证券日报网讯 9月2日晚间，红星发展发布公告称，2025年半年度利润分配方案为A股每股现金红利0.03 元（含税），股权登记日为2025年9月10日，除权（息）日及现金红利发放日均为2025年9月11日。 （文章来源：证券日报） ...

证券代码：600367 证券简称：红星发展 公告编号：2025-040 贵州红星发展股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.03元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/9/10 | － | 2025/9/11 | 2025/9/11 | 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 贵州红星发展股份有限公司2025 年 5 月 22 日的2024年年度股东会授权董事会 实施公司 2025 年中期利润分配方案，公司 2025 年中期利润分配现金分红金额不 高于 2025 年半年度合并报表归属于上市公司股东的净利润的 30%。本利润分配方 案经公司 2025 年 8 月 21 日召开的第九届董事会第六次会议审议通过。 二、 分配方案 2. 分派对象： 截至股权登记 ...

Core Viewpoint - On August 27, a total of 21 A-share listed companies disclosed their shareholding reduction situations, while Zhonghong Medical announced an increase in shareholding by its general manager [1][2]. Group 1: Shareholding Increase - Zhonghong Medical's general manager, Yang Hao, plans to increase his holdings by no less than 50,000 shares [2]. Group 2: Shareholding Reduction - Keda Intelligent's actual controller, Huang Mingsong, cumulatively reduced his holdings by 4.5 million shares from August 26 to 27 [2]. - Wei Ning Health's directors and senior management, Wang Tao and Wang Li, plan to reduce their shareholdings [2]. - Guoxin Technology's shareholders, including the National Integrated Circuit Industry Investment Fund, plan to collectively reduce their holdings by no more than 5% [2]. - Jingyan Technology's shareholder, Shi Juanhua, intends to reduce his holdings by no more than 0.89% [2]. - Yalian Development's shareholder, Qian Dezhen, plans to reduce his holdings by no more than 2% [2]. - New Network's shareholders, Hongta Innovation and Sun Xiujie, plan to reduce their holdings by no more than 2% [2]. - Hangzhou Garden's shareholders plan to reduce their holdings by no more than 3% [2]. - Dongxin Technology's controlling shareholder and its concerted actors will see their shareholding ratio drop to 37.47% [2]. - Miaokelando's vice chairman and general manager, Chai Zhuo, plans to reduce his holdings by no more than 1.95% [2]. - Fudan Zhangjiang's shareholder, Wang Haibo, plans to reduce his holdings by no more than 0.01% [2]. - Kangchen Pharmaceutical's executive, Niu Zhanqi, plans to reduce his holdings by no more than 87,500 shares [2]. - Fulaite's controlling shareholder and directors intend to collectively reduce their holdings by no more than 2.1333% [2]. - Hehui Optoelectronics' Shanghai Integrated Circuit Industry Investment Fund plans to reduce its holdings by no more than 2% [2]. - Cambridge Technology's controlling shareholder reduced his holdings by 1.8 million shares [2]. - Tuojing Technology's directors and supervisors plan to collectively reduce their holdings by no more than 0.0522% [2]. - Hongxing Development's senior management, Liu Zhengtai, plans to reduce his holdings by no more than 15,300 shares [2]. - Su Bian Electric's executive, Li Daiping, plans to reduce his holdings by no more than 0.03% [2]. - Haohan Depth's Feng Yanjun plans to reduce his holdings by no more than 72,000 shares [2]. - Zhejiang University Network's shareholder, Wangxin Group, plans to reduce its holdings by no more than 0.97% [2]. - Youfa Group's executive, Han Deheng, plans to reduce his holdings by no more than 0.27% [2]. - Hengyin Technology's Wang Shuqin plans to reduce his holdings by no more than 15,615,600 shares [2].

证券代码：600367 证券简称：红星发展 公告编号：2025-039 贵州红星发展股份有限公司 高级管理人员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 高级管理人员持股的基本情况 截止本公告日，贵州红星发展股份有限公司（下称公司）高级管理人员刘正 涛先生持有公司股份 61,200 股，占公司总股本的 0.0179%，股份来源为限制性 股票激励计划授予取得的股份。 ? 减持计划的主要内容 刘正涛先生因个人资金需求，自本公告披露之日起 15 个交易日后 3 个月内 （窗口期等不减持股份），拟通过集中竞价方式减持其所持有的公司股份合计不 超过 15,300 股，约占公司股份总数的 0.0045%。减持价格根据减持时的市场价 格确定。若减持期间公司有送股、资本公积转增股本等变动事项，应对上述减持 数量做相应调整。 一、减持主体的基本情况 股东名称 刘正涛 控股股东、实控人及一致行动人 □是 √否 直接持股 5%以上股东 □是 √否 股东身份 上述减持主体无一致行动人。 二、减持计划 ...

红星发展公告，公司高级管理人员刘正涛持有股份61200股，占0.0179%，因个人资金需求，计划自公 告披露之日起15个交易日后的3个月内，通过集中竞价方式减持不超过15300股，约占公司股份总数 0.0045%，减持期间为2025年9月19日～2025年12月18日，减持价格以减持时市场价格为准。 ...